Milestone Pharmaceuticals (MIST) Earnings Date & Reports

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

MIST is expected to report earnings to rise 2.71% to -21 cents per share on November 17

Milestone Pharmaceuticals MIST Stock Earnings Reports

Q3'26

Est.

$-0.22

Q2'26

Missed

by $0.02

Q1'26

Missed

by $0.43

Q4'25

Est.

$-0.16

Q3'25

Beat

by $0.04

The last earnings report on August 12 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 2.48M shares outstanding, the current market capitalization sits at 122.34M.

View a ticker or compare two or three

MIST

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for MIST